Showing results (111-120 of 167) with videos related to
Sort By:
Pageof 17
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 22, 2001
Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinomaR J Motzer, A Rakhit, J A Thompson, et al.Anti-Cancer Drugs|February 1, 2007
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesionsSvetislava J Vukelja, Stephen P Anthony, James C Arseneau, et al.Stem Cells (Dayton, Ohio)|July 1, 1995
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trialsC L Bennett, S L George, J M Vose, et al.Bone Marrow Transplantation|June 1, 1995
Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantationJ Nemunaitis, C S Rosenfeld, R Ash, et al.Bone Marrow Transplantation|January 1, 1991
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancyJ Nemunaitis, J W Singer, C D Buckner, et al.Blood|August 15, 1991
Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infectionsJ Nemunaitis, J D Meyers, C D Buckner, et al.The New England Journal of Medicine|June 20, 1991
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancerJ Nemunaitis, S N Rabinowe, J W Singer, et al.Current Molecular Medicine|December 24, 2015
Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal AdenocarcinomaG Zhou, J Yu, A Wang, et al.Blood|April 1, 1993
Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignanciesS N Rabinowe, D Neuberg, P J Bierman, et al.Cancer Gene Therapy|August 5, 2021
Tumor suppressor immune gene therapy to reverse immunotherapy resistanceSunil Chada, Dora Wiederhold, Kerstin B Menander, et al.Pageof 17